Profound Medical Corp. Statistics
Share Statistics
Profound Medical Corp. has 30.03M shares outstanding. The number of shares has increased by 22.92% in one year.
| Shares Outstanding | 30.03M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 22.66% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 25.94M |
| Failed to Deliver (FTD) Shares | 1 |
| FTD / Avg. Volume | 0% |
Short Selling Information
The latest short interest is 338.24K, so 1.13% of the outstanding shares have been sold short.
| Short Interest | 338.24K |
| Short % of Shares Out | 1.13% |
| Short % of Float | 1.3% |
| Short Ratio (days to cover) | 4.28 |
Valuation Ratios
The PE ratio is -6.2 and the forward PE ratio is -9.05.
| PE Ratio | -6.2 |
| Forward PE | -9.05 |
| PS Ratio | 24.62 |
| Forward PS | 4.4 |
| PB Ratio | 5.69 |
| P/FCF Ratio | -7.95 |
| PEG Ratio | n/a |
Enterprise Valuation
Profound Medical Corp. has an Enterprise Value (EV) of 161.66M.
| EV / Earnings | -5.66 |
| EV / Sales | 22.46 |
| EV / EBITDA | -6.04 |
| EV / EBIT | -5.65 |
| EV / FCF | -7.25 |
Financial Position
The company has a current ratio of 6.58, with a Debt / Equity ratio of 0.23.
| Current Ratio | 6.58 |
| Quick Ratio | 5.48 |
| Debt / Equity | 0.23 |
| Total Debt / Capitalization | 18.56 |
| Cash Flow / Debt | -3.14 |
| Interest Coverage | -37.16 |
Financial Efficiency
Return on equity (ROE) is -0.92% and return on capital (ROIC) is -72.82%.
| Return on Equity (ROE) | -0.92% |
| Return on Assets (ROA) | -0.65% |
| Return on Capital (ROIC) | -72.82% |
| Revenue Per Employee | 54.95K |
| Profits Per Employee | -218.08K |
| Employee Count | 131 |
| Asset Turnover | 0.16 |
| Inventory Turnover | 0.4 |
Taxes
| Income Tax | -128.00K |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -7.39% in the last 52 weeks. The beta is 0.83, so Profound Medical Corp.'s price volatility has been higher than the market average.
| Beta | 0.83 |
| 52-Week Price Change | -7.39% |
| 50-Day Moving Average | 7.7 |
| 200-Day Moving Average | 8.24 |
| Relative Strength Index (RSI) | 44.37 |
| Average Volume (20 Days) | 69.61K |
Income Statement
In the last 12 months, Profound Medical Corp. had revenue of 7.20M and earned -28.57M in profits. Earnings per share was -1.35.
| Revenue | 7.20M |
| Gross Profit | 4.38M |
| Operating Income | -28.62M |
| Net Income | -28.57M |
| EBITDA | -26.78M |
| EBIT | -28.62M |
| Earnings Per Share (EPS) | -1.35 |
Balance Sheet
The company has 26.21M in cash and 7.94M in debt, giving a net cash position of 18.27M.
| Cash & Cash Equivalents | 26.21M |
| Total Debt | 7.94M |
| Net Cash | 18.27M |
| Retained Earnings | -217.93M |
| Total Assets | 42.23M |
| Working Capital | 34.21M |
Cash Flow
In the last 12 months, operating cash flow was -22.30M and capital expenditures 0.19, giving a free cash flow of -22.30M.
| Operating Cash Flow | -22.30M |
| Capital Expenditures | 0.19 |
| Free Cash Flow | -22.30M |
| FCF Per Share | -1.05 |
Margins
Gross margin is 60.87%, with operating and profit margins of -397.5% and -396.85%.
| Gross Margin | 60.87% |
| Operating Margin | -397.5% |
| Pretax Margin | -398.62% |
| Profit Margin | -396.85% |
| EBITDA Margin | -372.01% |
| EBIT Margin | -397.5% |
| FCF Margin | -309.72% |
Dividends & Yields
PROF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -18.57% |
| FCF Yield | -10.22% |
Analyst Forecast
The average price target for PROF is $11.4, which is 56.8% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $11.4 |
| Price Target Difference | 56.8% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
Stock Splits
The last stock split was on Oct 16, 2019. It was a backward split with a ratio of 1:10.
| Last Split Date | Oct 16, 2019 |
| Split Type | backward |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | 3.33 |
| Piotroski F-Score | 4 |